nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ATP1A1—gall bladder—bile duct cancer	0.0165	0.0722	CbGeAlD
Bepridil—KCNQ1—pancreas—bile duct cancer	0.0159	0.0696	CbGeAlD
Bepridil—CALM2—gall bladder—bile duct cancer	0.0146	0.0635	CbGeAlD
Bepridil—CACNA1D—pancreas—bile duct cancer	0.011	0.0482	CbGeAlD
Bepridil—PDE1A—liver—bile duct cancer	0.0109	0.0476	CbGeAlD
Bepridil—KCNQ1—liver—bile duct cancer	0.0101	0.0443	CbGeAlD
Bepridil—PDE1B—lymph node—bile duct cancer	0.00998	0.0436	CbGeAlD
Bepridil—TNNC1—lymph node—bile duct cancer	0.00957	0.0418	CbGeAlD
Bepridil—CALM3—pancreas—bile duct cancer	0.00854	0.0373	CbGeAlD
Bepridil—CACNA1H—liver—bile duct cancer	0.00852	0.0372	CbGeAlD
Bepridil—PDE1A—lymph node—bile duct cancer	0.00836	0.0365	CbGeAlD
Bepridil—CACNA2D2—lymph node—bile duct cancer	0.00805	0.0351	CbGeAlD
Bepridil—KCNQ1—lymph node—bile duct cancer	0.00778	0.0339	CbGeAlD
Bepridil—ATP1A1—pancreas—bile duct cancer	0.00762	0.0333	CbGeAlD
Bepridil—CACNA1D—liver—bile duct cancer	0.00703	0.0307	CbGeAlD
Bepridil—CALM2—pancreas—bile duct cancer	0.00671	0.0293	CbGeAlD
Bepridil—CALM1—pancreas—bile duct cancer	0.00668	0.0291	CbGeAlD
Bepridil—CACNA1H—lymph node—bile duct cancer	0.00653	0.0285	CbGeAlD
Bepridil—CALM3—liver—bile duct cancer	0.00544	0.0237	CbGeAlD
Bepridil—CACNA1D—lymph node—bile duct cancer	0.00539	0.0235	CbGeAlD
Bepridil—CACNA1C—lymph node—bile duct cancer	0.00498	0.0217	CbGeAlD
Bepridil—ATP1A1—liver—bile duct cancer	0.00485	0.0212	CbGeAlD
Bepridil—CALM2—liver—bile duct cancer	0.00427	0.0186	CbGeAlD
Bepridil—CALM1—liver—bile duct cancer	0.00425	0.0185	CbGeAlD
Bepridil—CALM3—lymph node—bile duct cancer	0.00417	0.0182	CbGeAlD
Bepridil—ATP1A1—lymph node—bile duct cancer	0.00372	0.0162	CbGeAlD
Bepridil—CALM2—lymph node—bile duct cancer	0.00327	0.0143	CbGeAlD
Bepridil—CALM1—lymph node—bile duct cancer	0.00326	0.0142	CbGeAlD
Bepridil—KCNH2—lymph node—bile duct cancer	0.00296	0.0129	CbGeAlD
Bepridil—ABCB1—pancreas—bile duct cancer	0.00267	0.0116	CbGeAlD
Bepridil—CYP2D6—liver—bile duct cancer	0.00236	0.0103	CbGeAlD
Bepridil—ABCB1—liver—bile duct cancer	0.0017	0.0074	CbGeAlD
Bepridil—ABCB1—lymph node—bile duct cancer	0.0013	0.00568	CbGeAlD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000263	0.000341	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000262	0.00034	CbGpPWpGaD
Bepridil—CALM2—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00026	0.000337	CbGpPWpGaD
Bepridil—CALM1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00026	0.000337	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000253	0.000329	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000253	0.000329	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—NRAS—bile duct cancer	0.000253	0.000328	CbGpPWpGaD
Bepridil—PDE1A—Immune System—NRAS—bile duct cancer	0.000252	0.000327	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EGFR—bile duct cancer	0.000252	0.000326	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—EGFR—bile duct cancer	0.000251	0.000326	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000251	0.000325	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—IDH1—bile duct cancer	0.00025	0.000325	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000248	0.000322	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—EGFR—bile duct cancer	0.000243	0.000315	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—EGFR—bile duct cancer	0.000243	0.000315	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000243	0.000315	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000243	0.000315	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—GNAS—bile duct cancer	0.00024	0.000311	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—KRAS—bile duct cancer	0.000238	0.000308	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—KRAS—bile duct cancer	0.000237	0.000308	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—IDH1—bile duct cancer	0.000236	0.000306	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PTGS2—bile duct cancer	0.000235	0.000305	CbGpPWpGaD
Bepridil—PDE1A—Disease—NRAS—bile duct cancer	0.000233	0.000302	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—GNAS—bile duct cancer	0.000232	0.000301	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GNAS—bile duct cancer	0.000232	0.000301	CbGpPWpGaD
Bepridil—PDE1B—Immune System—NRAS—bile duct cancer	0.000231	0.000299	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EGFR—bile duct cancer	0.00023	0.000299	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EGFR—bile duct cancer	0.00023	0.000298	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—KRAS—bile duct cancer	0.000229	0.000297	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—KRAS—bile duct cancer	0.000229	0.000297	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000221	0.000286	CbGpPWpGaD
Bepridil—CALM3—Metabolism—SLC5A5—bile duct cancer	0.000218	0.000283	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—KRAS—bile duct cancer	0.000217	0.000282	CbGpPWpGaD
Bepridil—PDE1A—Immune System—KRAS—bile duct cancer	0.000217	0.000282	CbGpPWpGaD
Bepridil—PDE1A—Disease—TGFB1—bile duct cancer	0.000216	0.000281	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—ERBB2—bile duct cancer	0.000214	0.000278	CbGpPWpGaD
Bepridil—PDE1B—Disease—NRAS—bile duct cancer	0.000213	0.000276	CbGpPWpGaD
Bepridil—PDE1A—Disease—EGFR—bile duct cancer	0.000212	0.000275	CbGpPWpGaD
Bepridil—CALM1—Metabolism—SLC5A5—bile duct cancer	0.000211	0.000273	CbGpPWpGaD
Bepridil—CALM2—Metabolism—SLC5A5—bile duct cancer	0.000211	0.000273	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EGFR—bile duct cancer	0.00021	0.000273	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFBR2—bile duct cancer	0.00021	0.000272	CbGpPWpGaD
Bepridil—CALM3—Immune System—HGF—bile duct cancer	0.000209	0.000271	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—ERBB2—bile duct cancer	0.000207	0.000268	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PTGS2—bile duct cancer	0.000206	0.000268	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—HRAS—bile duct cancer	0.000206	0.000267	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFBR2—bile duct cancer	0.000203	0.000263	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFBR2—bile duct cancer	0.000203	0.000263	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—HRAS—bile duct cancer	0.000202	0.000262	CbGpPWpGaD
Bepridil—CALM1—Immune System—HGF—bile duct cancer	0.000202	0.000262	CbGpPWpGaD
Bepridil—CALM2—Immune System—HGF—bile duct cancer	0.000202	0.000262	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—HRAS—bile duct cancer	0.000202	0.000261	CbGpPWpGaD
Bepridil—PDE1A—Disease—KRAS—bile duct cancer	0.000201	0.00026	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—ERBB2—bile duct cancer	0.0002	0.000259	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—ERBB2—bile duct cancer	0.0002	0.000259	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—HRAS—bile duct cancer	0.000199	0.000258	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—HRAS—bile duct cancer	0.000199	0.000258	CbGpPWpGaD
Bepridil—PDE1B—Immune System—KRAS—bile duct cancer	0.000199	0.000258	CbGpPWpGaD
Bepridil—CALM3—Disease—SMAD4—bile duct cancer	0.000198	0.000257	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—ERBB2—bile duct cancer	0.000198	0.000257	CbGpPWpGaD
Bepridil—PDE1B—Disease—TGFB1—bile duct cancer	0.000198	0.000257	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—ERBB2—bile duct cancer	0.000196	0.000254	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—HRAS—bile duct cancer	0.000195	0.000253	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—HRAS—bile duct cancer	0.000195	0.000253	CbGpPWpGaD
Bepridil—PDE1B—Disease—EGFR—bile duct cancer	0.000194	0.000252	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—bile duct cancer	0.000193	0.000251	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—bile duct cancer	0.000193	0.00025	CbGpPWpGaD
Bepridil—CALM2—Disease—SMAD4—bile duct cancer	0.000192	0.000249	CbGpPWpGaD
Bepridil—CALM1—Disease—SMAD4—bile duct cancer	0.000192	0.000249	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ERBB2—bile duct cancer	0.000192	0.000249	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ERBB2—bile duct cancer	0.000192	0.000249	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—bile duct cancer	0.000187	0.000242	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—bile duct cancer	0.000187	0.000242	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—HRAS—bile duct cancer	0.000185	0.00024	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HRAS—bile duct cancer	0.000185	0.000239	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MMP9—bile duct cancer	0.000184	0.000239	CbGpPWpGaD
Bepridil—PDE1B—Disease—KRAS—bile duct cancer	0.000183	0.000238	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—bile duct cancer	0.000177	0.000229	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—bile duct cancer	0.000177	0.000229	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—NRAS—bile duct cancer	0.000175	0.000226	CbGpPWpGaD
Bepridil—PDE1A—Disease—HRAS—bile duct cancer	0.00017	0.000221	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GNAS—bile duct cancer	0.000169	0.00022	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HRAS—bile duct cancer	0.000169	0.000219	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—NRAS—bile duct cancer	0.000169	0.000219	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—NRAS—bile duct cancer	0.000169	0.000219	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MMP9—bile duct cancer	0.000168	0.000218	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SLC5A5—bile duct cancer	0.000165	0.000214	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GNAS—bile duct cancer	0.000164	0.000212	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GNAS—bile duct cancer	0.000164	0.000212	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NRAS—bile duct cancer	0.000163	0.000212	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—bile duct cancer	0.000163	0.000212	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TGFB1—bile duct cancer	0.000162	0.00021	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—bile duct cancer	0.000162	0.00021	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—NRAS—bile duct cancer	0.000157	0.000204	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TGFB1—bile duct cancer	0.000157	0.000203	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TGFB1—bile duct cancer	0.000157	0.000203	CbGpPWpGaD
Bepridil—PDE1B—Disease—HRAS—bile duct cancer	0.000156	0.000202	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SLC5A5—bile duct cancer	0.000156	0.000202	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—NRAS—bile duct cancer	0.000152	0.000197	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—NRAS—bile duct cancer	0.000152	0.000197	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TGFB1—bile duct cancer	0.000152	0.000197	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—NRAS—bile duct cancer	0.000151	0.000196	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—KRAS—bile duct cancer	0.00015	0.000195	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NRAS—bile duct cancer	0.000149	0.000194	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—bile duct cancer	0.000149	0.000194	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—bile duct cancer	0.000149	0.000193	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS2—bile duct cancer	0.000148	0.000192	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFBR2—bile duct cancer	0.000147	0.00019	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NRAS—bile duct cancer	0.000146	0.000189	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NRAS—bile duct cancer	0.000146	0.000189	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—KRAS—bile duct cancer	0.000145	0.000188	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—KRAS—bile duct cancer	0.000145	0.000188	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—bile duct cancer	0.000143	0.000186	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS2—bile duct cancer	0.000143	0.000185	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS2—bile duct cancer	0.000143	0.000185	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFBR2—bile duct cancer	0.000142	0.000184	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000142	0.000184	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNAS—bile duct cancer	0.000142	0.000184	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KRAS—bile duct cancer	0.00014	0.000182	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SMAD4—bile duct cancer	0.000139	0.00018	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—bile duct cancer	0.000139	0.00018	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—bile duct cancer	0.000138	0.00018	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—bile duct cancer	0.000138	0.00018	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—bile duct cancer	0.000137	0.000178	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNAS—bile duct cancer	0.000137	0.000178	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNAS—bile duct cancer	0.000137	0.000178	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—bile duct cancer	0.000136	0.000176	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KRAS—bile duct cancer	0.000135	0.000175	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SMAD4—bile duct cancer	0.000134	0.000174	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SMAD4—bile duct cancer	0.000134	0.000174	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—bile duct cancer	0.000133	0.000173	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—bile duct cancer	0.000133	0.000172	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—bile duct cancer	0.000133	0.000172	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KRAS—bile duct cancer	0.000131	0.00017	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KRAS—bile duct cancer	0.000131	0.00017	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KRAS—bile duct cancer	0.00013	0.000168	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—bile duct cancer	0.000129	0.000168	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—bile duct cancer	0.000129	0.000168	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KRAS—bile duct cancer	0.000128	0.000167	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GNAS—bile duct cancer	0.000128	0.000166	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—HRAS—bile duct cancer	0.000128	0.000166	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KRAS—bile duct cancer	0.000126	0.000163	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KRAS—bile duct cancer	0.000126	0.000163	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—bile duct cancer	0.000125	0.000162	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—HRAS—bile duct cancer	0.000123	0.00016	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—HRAS—bile duct cancer	0.000123	0.00016	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNAS—bile duct cancer	0.000121	0.000157	CbGpPWpGaD
Bepridil—CALM3—Immune System—ERBB2—bile duct cancer	0.00012	0.000156	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—bile duct cancer	0.000119	0.000155	CbGpPWpGaD
Bepridil—CALM2—Immune System—ERBB2—bile duct cancer	0.000116	0.000151	CbGpPWpGaD
Bepridil—CALM1—Immune System—ERBB2—bile duct cancer	0.000116	0.000151	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—bile duct cancer	0.000115	0.000149	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—bile duct cancer	0.000114	0.000148	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—bile duct cancer	0.000114	0.000148	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—bile duct cancer	0.000111	0.000144	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—bile duct cancer	0.000111	0.000144	CbGpPWpGaD
Bepridil—CALM3—Disease—ERBB2—bile duct cancer	0.000111	0.000144	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—bile duct cancer	0.00011	0.000143	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—bile duct cancer	0.00011	0.000143	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—bile duct cancer	0.000109	0.000142	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—bile duct cancer	0.000109	0.000141	CbGpPWpGaD
Bepridil—CALM1—Disease—ERBB2—bile duct cancer	0.000107	0.000139	CbGpPWpGaD
Bepridil—CALM2—Disease—ERBB2—bile duct cancer	0.000107	0.000139	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—bile duct cancer	0.000107	0.000138	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—bile duct cancer	0.000107	0.000138	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—bile duct cancer	0.000106	0.000138	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—bile duct cancer	0.000106	0.000138	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—bile duct cancer	0.000105	0.000136	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—bile duct cancer	0.000105	0.000136	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—bile duct cancer	0.000104	0.000136	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—NRAS—bile duct cancer	0.0001	0.00013	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—bile duct cancer	9.69e-05	0.000126	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—bile duct cancer	9.69e-05	0.000126	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—bile duct cancer	9.15e-05	0.000119	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—bile duct cancer	9.12e-05	0.000118	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—bile duct cancer	9.09e-05	0.000118	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—bile duct cancer	8.85e-05	0.000115	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—bile duct cancer	8.85e-05	0.000115	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—bile duct cancer	8.83e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—bile duct cancer	8.83e-05	0.000114	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—bile duct cancer	8.8e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—bile duct cancer	8.8e-05	0.000114	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—bile duct cancer	8.62e-05	0.000112	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—bile duct cancer	8.45e-05	0.00011	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—bile duct cancer	8.34e-05	0.000108	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—bile duct cancer	8.34e-05	0.000108	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—bile duct cancer	8.34e-05	0.000108	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—bile duct cancer	8.17e-05	0.000106	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—bile duct cancer	8.17e-05	0.000106	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—bile duct cancer	8.06e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—bile duct cancer	8.06e-05	0.000105	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—bile duct cancer	7.88e-05	0.000102	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—bile duct cancer	7.85e-05	0.000102	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—bile duct cancer	7.78e-05	0.000101	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—bile duct cancer	7.7e-05	9.98e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—bile duct cancer	7.62e-05	9.88e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—bile duct cancer	7.62e-05	9.88e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—bile duct cancer	7.59e-05	9.85e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—bile duct cancer	7.59e-05	9.85e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—bile duct cancer	7.52e-05	9.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—bile duct cancer	7.52e-05	9.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—bile duct cancer	7.45e-05	9.66e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—bile duct cancer	7.45e-05	9.66e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—bile duct cancer	7.33e-05	9.5e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—bile duct cancer	7.27e-05	9.43e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—bile duct cancer	7.09e-05	9.19e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—bile duct cancer	7.09e-05	9.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—bile duct cancer	7.03e-05	9.12e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—bile duct cancer	7.03e-05	9.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—bile duct cancer	7.01e-05	9.1e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—bile duct cancer	6.89e-05	8.94e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—bile duct cancer	6.78e-05	8.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—bile duct cancer	6.78e-05	8.8e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—bile duct cancer	6.69e-05	8.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—bile duct cancer	6.67e-05	8.65e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—bile duct cancer	6.49e-05	8.42e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—bile duct cancer	6.48e-05	8.4e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—bile duct cancer	6.48e-05	8.4e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—bile duct cancer	6.45e-05	8.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—bile duct cancer	6.45e-05	8.37e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—bile duct cancer	6.41e-05	8.31e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—bile duct cancer	6.2e-05	8.04e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—bile duct cancer	6.2e-05	8.04e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—bile duct cancer	6.18e-05	8.02e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—bile duct cancer	5.98e-05	7.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—bile duct cancer	5.98e-05	7.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—bile duct cancer	5.92e-05	7.67e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—bile duct cancer	5.92e-05	7.67e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—bile duct cancer	5.72e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—bile duct cancer	5.72e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—bile duct cancer	5.72e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—bile duct cancer	5.72e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—bile duct cancer	5.5e-05	7.13e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—bile duct cancer	5.39e-05	6.99e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—bile duct cancer	5.32e-05	6.9e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—bile duct cancer	5.32e-05	6.9e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—bile duct cancer	5.21e-05	6.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—bile duct cancer	5.21e-05	6.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—bile duct cancer	5.09e-05	6.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—bile duct cancer	4.93e-05	6.39e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—bile duct cancer	4.93e-05	6.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—bile duct cancer	4.53e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—bile duct cancer	4.38e-05	5.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—bile duct cancer	4.38e-05	5.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—bile duct cancer	4.33e-05	5.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—bile duct cancer	4.19e-05	5.43e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—bile duct cancer	4.19e-05	5.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—bile duct cancer	4.14e-05	5.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—bile duct cancer	4.01e-05	5.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—bile duct cancer	4.01e-05	5.2e-05	CbGpPWpGaD
